Parallel to SYK, Sphingosine kinase 2 (SK2) has the ability of acetylating histone H3 within the MYC gene, which induces a MYC-mediated oncogenicity in ALL-mouse models. The gene discussed is MYC; the disease is acute lymphoblastic leukemia.